PPP1R14B and bladder transitional cell carcinoma: PHI-1 gene amplifications, as reported by Deng et al. [36], are observed in cancers such as BLCA, PRAD, and liver hepatocellular carcinoma (LIHC), leading to elevated PHI-1 expression.